The Oct-2 transcription factor was originally identified as an activator of transcription in B lymphocytes (29, 30) . Thus, this protein can activate promoters such as those of the immunoglobulin genes which contain its DNA-binding site (ATG CAAAT) both in B lymphocytes (25) and following the artificial expression of Oct-2 in cells such as fibroblasts which do not normally express this protein (20) .
Interestingly however, Oct-2-specific mRNAs have been detected in the nervous system (10, 11, 32) , and an octamerbinding protein with the mobility of Oct-2 has been identified in the brain with the use of a DNA mobility shift assay (26) . However, comparison of the activities of B-cell and neuronal Oct-2 has indicated that in contrast to B-cell Oct-2, neuronal Oct-2 can function as a repressor of transcription (5, 32) . Thus, neuronal Oct-2 was responsible for the repression of the herpes simplex virus (HSV) immediate-early (IE) genes in neuronal cells (15) , which is dependent on the octamer-related TAATGARAT motif in the IE promoters (12) and results in the clinically important phenomenon of latent infection (13) . Hence, the Oct-2 protein can function as a repressor or activator of transcription, depending on the cell type studied.
Although Oct-2 is encoded by a single gene in the mammalian genome (4, 25, 29) , the protein exists in a number of different isoforms which are produced by alternative splicing of the Oct-2 RNA (35) . Moreover, the pattern of splicing in neuronal cells differs from that in B cells; hence, different forms of the protein predominate in the two cell types (17, 32) . Although all of the different forms of the protein can transactivate a simple octamer-containing promoter when cotransfected into fibroblasts (35) , in agreement with earlier results (20) , they differ in their effects on the HSV IE promoters in similar cotransfections (17) . Thus, while the predominant B-cell form Oct 2.1 can activate the HSV IE3 promoter when cotransfected into fibroblasts, the predominant neuronal forms Oct 2.4 and 2.5 (also called Oct-2B [21] ) can repress it (17) . To identify the reasons for the different activities of the various forms of Oct-2, we have attempted to characterize the features of Oct-2 which are necessary for the repression of IE promoter activity.
MATERUILS AND METHODS
Plasmid DNAs. The target octamer-containing promoters used in this study were the HSV IE3 gene promoter (from -330 to +33) linked to the chloramphenicol acetyltransferase (CAT) gene (IE-CAT [31] ), a simple promoter containing a consensus octamer motif linked to the TATA box and transcriptional start site of the c-fos gene and the CAT gene and lacking any other transcription factor binding sites (Oct-CAT [36] ), and the tyrosine hydroxylase promoter from -272 to +27 driving expression of the CAT gene (14) . These target plasmids were transfected with either the cDNA clone of one of the different alternatively spliced forms of Oct-2 under the control of the constitutive IE promoter of cytomegalovirus (CMV) (35) or a series of Oct-2 mutants lacking either the entire Nor C-terminal region (21) or containing different Nor C-terminal deletions (6, 21) . The POU domain plasmid was prepared by PCR amplification of an Oct-2 cDNA clone with appropriate oligonucleotides and, following addition of an ATG translation start codon, was cloned into the pJ7 expression vector.
DNA transfection. BHK-21 cells (clone 13 [19] ), which lack endogenous Oct-2 (15, 17) , were transfected by the method of Gorman et al. (8) . Transfections were carried out with 2 x 106 cells on a 90-mm-diameter plate transfected with 10 ,ug of the Oct-2 expression vectors.
CAT assays. Assays of CAT activity in the transfected cells were carried out as described by Gorman ). The region rich in proline, leucine, and glutamine residues (PLQ), the POU-specific (POU) and homeobox (Homeo) regions which together form the DNA-binding POU domain, and a potential leucine zipper region (Leu) are indicated. The position of a 16-amino-acid insert (17) found in Oct 2.2 but not in Oct 2.1 (35) is indicated.
having been previously equalized for protein content as described by Bradford (3). The percentage conversion of chloramphenicol to the acetylated form was determined by scintillation counting of the regions of the thin-layer chromatography plate corresponding to the acetylated and nonacetylated forms as detected by autoradiography. In all cases, the values obtained were equalized for differences in plasmid uptake between samples based on the results of dot blot hybridization of an aliquot of the transfected cell extract with a CAT DNA probe (12) .
RESULTS
In our previous experiments (17), Oct 2.1, 2.2, and 2.3 (also collectively called Oct-2A [20] ), which differ only at the N terminus of the protein (35) , were all able to activate the IE3 gene promoter upon cotransfection into BHK cells, whereas Oct 2.4 and 2.5 (Oct-2B), which differ from the other forms at the C terminus but have the same N terminus as Oct 2.1, were able to repress it. We therefore tested a series of C-terminal deletions based upon Oct 2.1 (6) ( Fig. 1) for the ability to modulate the activity of the IE3 promoter contained in the plasmid IE-CAT (31) . As a control, these plasmids were also tested for the ability to activate a simple octamer-containing promoter (Oct-CAT) which can be activated by all the Oct-2 forms upon cotransfection of BHK cells (17, 36) . In all cases, these mutant forms of Oct-2 had been shown to be expressed at similar levels in transfected HeLa cells (6) or BHK cells (data not shown), indicating that any differences in their effects on cotransfected promoters would be dependent on real differences in activity rather than on differences in the levels to which they accumulate in the transfected cells.
In these experiments ( Fig. 2a ), any interference with the C-terminal region of Oct 2.1 eliminated its ability to activate the IE3 promoter and resulted in a factor which was able to repress the IE3 promoter. Although all of the C-terminal deletions were able to repress the IE promoter, the most severe repression was observed with the various mutants which lack the region from amino acids 377 to 399 either alone or with additional losses C terminal to this region. Interestingly, the region from amino acids 377 to 399 contains a putative leucine zipper potentially capable of mediating the homodimerization of Oct 2.1 or its heterodimerization with other proteins (4, 20, 25) .
In contrast to the repressive effect of the C-terminal deletions on the IE3 promoter, all of the deletions retained some ability to activate the Oct-CAT construct containing only an octamer motif and TATA box (36) , although this ability was impaired in all cases relative to the wild-type construct (Fig.  2b ). This ability parallels the activation of this promoter observed with all of the different forms of Oct-2, including Oct 2.4 and 2.5 (17) . Interestingly the deletion mutant lacking only amino acids 377 to 399 was the mutant least impaired in transactivation of the Oct-CAT reporter (Fig. 2b ) even though it was a strong repressor of the IE promoter ( Fig. 2a ). In agreement with our previous experiments using Oct 2.1, 2.4, and 2.5 (17) , none of the Oct-2 deletion mutants had any positive or negative effect on the activity of a control Rous sarcoma virus promoter, indicating that these effects are specific to promoters containing octamer or TAATGARAT motifs (data not shown).
These experiments indicate that any interference with the C-terminal region of Oct 2.1 eliminates its ability to activate the IE promoter and converts it into a repressor. The simplest mechanism by which this effect could operate would be for an Oct-2 molecule lacking the ability to activate the IE promoter to continue to bind to the TAATGARAT sequence and passively prevent the activation of the IE promoter by preventing the binding of other stimulatory octamer-binding proteins to this sequence (7) . To test whether this was the case, we prepared an expression construct containing only the isolated POU domain of Oct-2 and tested whether this region which contains the DNA-binding domain was able to repress the IE promoter. In these experiments ( Fig. 3a) , the isolated POU domain was able to moderately reduce the activity of the IE promoter when cotransfected into BHK cells. However, the degree of reduction in activity observed was much smaller than that seen with either the naturally occurring C-terminal variant Oct 2.4 or 2.5 or any of the artificial deletions of the C-terminal region ( Fig. 3a) , although the levels of expression observed with the isolated POU domain were higher than with the other constructs (data not shown). As expected, the isolated POU domain was also able to moderately reduce the activity of the Oct-CAT construct, presumably by preventing binding of stimulatory octamer-binding proteins. In this case, however, all of the other forms of Oct-2 transactivated the promoter as before (Fig. 3b ).
These findings suggest that in the case of the IE promoter, simple inhibition of DNA binding by a nonactivating form of Oct-2 does not account for the ability of the different forms of Oct-2 to repress the IE promoter. Moreover, the fact that strong repression can be achieved by a form lacking virtually the entire C terminus of the protein (amino acids 377 to 463) but not by the isolated POU domain suggests that the Nterminal region of the protein may be involved in this effect. To test this possibility, we examined the effects on the IE promoter of cotransfecting mutant forms of Oct-2 either containing the intact N terminus with the POU domain but lacking the entire C terminus or containing an intact C terminus linked to the POU domain but lacking the entire N terminus (21) .
In these experiments ( Fig. 4 ), the C-terminal deletion functioned as a very strong repressor of the IE promoter comparable in strength to that observed with the other extensive C-terminal deletions and with a much stronger effect than that observed with the isolated POU domain. This strong repression is observed even though this mutant is expressed at a similar level to wild-type Oct-2 in transfected cells (21) . In contrast, the N-terminal deletion functioned as a strong activator of the IE promoter, and the degree of stimulation observed was much stronger than that seen with the intact Oct-2 protein even though the two proteins are known to be expressed at similar levels in transfected cells (21) . Hence, these results suggest that an inhibitory domain at the N terminus of the protein is responsible for the ability of Oct 2.4, 2.5, and the C-terminal deletion mutants to repress the IE3 promoter. Moreover, the N-terminal domain also appears to limit the stimulation of the IE promoter which is observed even with forms of Oct-2 such as Oct 2.1 which have an intact C terminus and which are therefore capable of stimulating the promoter.
Interestingly, deletion of the N-terminal domain also enhanced the ability of Oct-2 to stimulate the Oct-CAT construct whereas deletion of the C-terminal domain reduced the acti-vation (Fig. 5a ). This finding suggests that the N-terminal domain can also limit the extent of activation on other promoters which can be activated via the C-terminal domain.
To further investigate this possibility, we tested the effect of the N-and C-terminal deletions on the tyrosine hydroxylase promoter, which we have previously shown to be repressed by all the forms of Oct-2 (4a). In these experiments (Fig. Sb) , this promoter was strongly repressed by the C-terminal deletion but was unaffected by the N-terminal deletion. This finding indicates that the C-terminal domain does not activate the tyrosine hydroxylase promoter whereas the N-terminal domain can repress it, accounting for our initial observation that all the forms of Oct-2 can repress this promoter regardless of their different C-terminal regions. As in our previous experiments with these naturally occurring forms of Oct-2, the inhibitory effect of the C-terminal deletion was dependent on the presence of a binding site for octamer-binding proteins in the tyrosine hydroxylase promoter, indicating the specific nature of this effect (data not shown).
Hence, the N-terminal inhibitory domain is capable of repressing several different octamer-containing promoters, with the precise effect observed in each case being dependent on the extent to which they are stimulated by the C-terminal activation domain. To map the N-terminal inhibitory domain, we used a series of N-terminal deletion mutants of Oct-2, all of which have been shown to be expressed at similar levels in transfected cells (21) (Fig. 6 ). In these experiments (Fig. 6 ), progressive N-terminal truncation of the N-terminal region of Oct 2.2 leaving the C terminus intact led to only a small increase in the ability to activate the IE3 promoter when up to the N-terminal 160 amino acids were deleted. However a further truncation removing the N-terminal 186 amino acids resulted in a large increase in transactivation, suggesting that amino acids 161 to 186 are critical for the inhibitory effect that we observe on the IE promoter. In agreement with this idea, an internal deletion of Oct 2.1 which lacked only amino acids 142 to 186 (6) showed an enhanced ability to activate the IE3 promoter, whereas deletion of amino acids 142 to 160 reduced the transactivation observed ( Fig. 6) . Similar results were also obtained when these deletions were assayed on the tyrosine hydroxylase promoter with a construct lacking the N-terminal 161 amino acids repressing the promoter, whereas one lacking the N-terminal 186 amino acids did not have such an effect (data not shown).
Having mapped the inhibitory domain, we wished to test whether this region could function when it was linked to the DNA-binding domain of another factor. We therefore cloned either the entire N terminus of Oct-2 or the region encoding amino acids 142 to 181 downstream of the DNA-binding domain of the yeast transcription factor GAL4 in the vector pSG424 (24) . These hybrid constructs were then cotransfected with a construct in which four DNA-binding sites for GAL4 had been cloned upstream of the thymidine kinase (tk) promoter. This promoter was chosen because it has a relatively high basal activity and had previously been used to map the inhibitory domains in other transcription factors (28) . In these experiments, a clear reduction in promoter activity was observed upon cotransfection of the promoter construct with the constructs containing either the entire N terminus or amino acids 142 to 181 compared with the level observed upon cotransfection of the pSG424 vector alone. Hence, both the entire N-terminal region and the isolated region from 142 to 181 can function to inhibit promoter activity in the absence of the POU domain when located C terminal to a heterologous DNA-binding domain (Fig. 7) .
To further investigate the activity of the isolated inhibitory domain, we cloned this region in the absence of the DNAbinding domain or other regions of Oct-2 together with an added ATG initiation codon downstream of the simian virus 40 promoter, allowing its expression in isolation. We then investigated the effect of this isolated region which cannot bind to DNA on the repression of the IE3 promoter by Oct 2.5. To do this, constant amounts of IE-CAT and of the Oct 2.5 expression plasmid were cotransfected into BHK cells in the presence of an increasing amount of the inhibitory domain expression plasmid and a correspondingly decreasing amount of the plasmid vector so as to maintain the amount of transfected 181) of Oct-2 or amino acids 142 to 181 linked to the GAL4 DNA-binding domain on the activity of constructs containing four binding sites for GAL4 upstream of the tk promoter (a) or the tk promoter lacking GAL4 binding sites (b). The effect of the isolated GAL4 DNA-binding domain on both promoters is also shown (GAL4). Results are expressed as percentages of promoter activity observed upon cotransfection of the expression vector lacking any inserted sequence derived from GAL4 or Oct-2 (V). Values are averages of two determinations whose ranges are shown by the bars.
DNA constant. In these experiments (Fig. 8) , the inhibitory effect of Oct 2.5 could be abolished by the inclusion of high levels of the inhibitory domain plasmid. Hence, this domain when present alone in trans in the absence of the DNA-binding domain can relieve the inhibitory effect of intact Oct-2 containing the DNA-binding domain as well as the inhibitory region. This observation indicates that the N-terminal region may function by recruiting a trans-acting inhibitory factor to the promoter, with this factor being titrated out by the isolated inhibitory domain expressed in isolation in the absence of the DNA-binding domain.
DISCUSSION
The simplest mechanism to account for the ability of different forms of Oct-2 to repress the HSV IE3 promoter would be that these forms can bind to the octamer/TAATGARAT motif in the IE promoter and prevent the binding of activating octamer-binding proteins while failing to activate the IE promoter themselves (see reference 7 for a review of mechanisms of gene repression by transcription factors). In agreement with this model, Stoykova et al. (32) have shown that a naturally occurring form of Oct-2 (Mini-Oct) consisting of VOL. 14, 1994 on virtually only the DNA-binding POU domain can repress the activation of octamer-containing promoters by endogenous octamer-containing factors in embryonal carcinoma cells, which contain several octamer-binding proteins not found in other cell types (21) . Similarly, we have recently shown (16) that the isolated POU domain of Oct-2 can prevent the activation of the TEl and IE3 promoters by the strong transactivating complex formed between the cellular transcription factor Oct-1 and the HSV virion protein Vmw65, which plays a critical role in activating the IE promoters following HSV infection of permissive cell types (22, 23) .
In contrast, as shown here, in uninfected BHK cells which contain only Oct-1, the isolated POU domain has only a weak effect on the basal activity of the IE3 promoter, and a similar weak effect is also observed when the POU domain and the IE promoter are cotransfected into the ND7 neuronal cell line (37) , which contains only Oct-1 in addition to endogenous Oct-2 (34) (data not shown). Such a finding is in agreement with the relatively weak transactivating ability of Oct-1 (33) in the absence of Vmw65, which would result in only a small reduction in the basal activity of the IE promoter even if binding of Oct-1 were prevented by the DNA-binding domain of Oct-2.
Hence, the inhibition of the IE promoter by neuronal forms of Oct-2 in transfected BHK cells or naturally in ND7 neuronal cells (15, 17) does not appear to operate solely via a mechanism in which DNA binding mediated via the POU domain of Oct-2 blocks the binding of a transactivating factor. Rather, the data presented here suggest that the N-terminal region of Oct-2 is required for this effect, whereas the C-terminal region of the protein present in Oct 2.1 or 2.2 antagonizes the effect and stimulates the IE promoter. Thus, deletion of the N-or C-terminal region results in a strong activator or a strong repressor, respectively, of transcription when tested on the IE promoter. Similarly, in forms of the protein such as Oct 2.1, which contain intact N and C termini, the activating effect of the C terminus predominates and the IE promoter is stimulated, whereas in forms of the protein with an altered C terminus such as Oct 2.4 and 2.5, the inhibitory effect of the N terminus predominates and the IE promoter is repressed.
The stimulation of the IE3 promoter is likely to be mediated by an activation domain which has been shown by a number of groups to be located at the C terminus of the molecule and which is responsible for the ability of Oct-2 to stimulate a variety of different octamer-containing promoters not activated by Oct-1 (2, 6, 33) . Interestingly, however, previous studies have suggested that this stimulatory effect is dependent on only the C-terminal 18 amino acids in the case of a promoter containing a proximal octamer motif (6) or the C-terminal 64 amino acids in the case of a downstream octamer-containing enhancer (2) . In neither case was any detrimental effect observed when the region from amino acids 377 to 399 containing a putative leucine zipper was deleted (2, 6) .
In contrast, in our experiments deletion of this region produced the strongest inhibitory effect on IE-CAT expression of all the mutants tested. This may indicate that the boundary of the C-terminal activation domain required is different for different octamer/TAATGARAT promoters, depending, for example, on the precise distance of the octamer motif from the promoter and/or on the nature of the other transcription factors binding in the vicinity. In agreement with this idea, we observed that deletion of the putative leucine zipper motif did have some effect on the ability of Oct-2 to stimulate the Oct-CAT construct, whereas Tanaka and Herr (33) found that deletion of all 122 amino acids of Oct-2 C terminal to the POU domain was required for the abolition of its ability to stimulate another octamer-containing promoter. It is therefore possible that the entire C-terminal region functions as an activation domain which directly stimulates the IE3 promoter. Alternatively, it remains possible that the C-terminal region of Oct-2 MOL. CELL. BIOL. stimulates the IE promoter indirectly by recruiting another activating molecule to the promoter via the leucine zipper motif.
Whatever the precise means by which it stimulates the IE promoter, it is clear that deletion or alteration of the Cterminal region allows a region located at the N terminus of the molecule to exert an inhibitory effect on transcription. This results in repression of the IE promoter below the basal level observed in the absence of Oct-2. Moreover, this region can also limit the degree of activation of a promoter that can be activated even by forms of Oct-2 with a truncated or altered C terminus. Thus, the degree of activation of the Oct-CAT construct was also enhanced in our experiments by deletion of the N-terminal region. Interestingly, the naturally occurring forms of Oct-2 as well as the C-terminal deletion are all capable of repressing the tyrosine hydroxylase promoter, whereas the N-terminal deletion does not affect the activity of this promoter. This finding suggests that on the tyrosine hydroxylase promoter, the C-terminal activation domain is inactive, allowing the N-terminal domain common to all of the different forms to exert its inhibitory effect. Hence, the precise effect of Oct 2.1 or 2.2. on a specific promoter may depend on the balance between the inhibitory effect of the N-terminal domain and the stimulatory effect of the C-terminal domain on that promoter.
Previous studies (21) have shown that deletion of the first 99 amino acids at the N terminus of Oct-2 results in an increase in its ability to activate two artificial octamer-containing promoters when tested in HeLa cells. In the case of the HSV IE3 promoter, however, deletion of this region did not significantly enhance the transactivating ability of Oct-2. Instead, we identified a region between amino acids 161 and 186 which appears to be responsible for the inhibitory effect that we observe. This element forms part of a short region (labelledin Fig. 1 ) which is rich in both acidic amino acids and proline residues, with seven prolines and six acidic residues being found in the 25 amino acids from positions 161 to 186. Interestingly, these 25 amino acids are interrupted by a 16-amino-acid insert in Oct 2.2 which is absent in the other forms (35) . This insert contains a further four prolines and one acidic residue and may enhance the inhibitory activity of the region, since whereas both Oct 2.1 and 2.2 can transactivate the IE3 promoter, we have observed that Oct 2.2 transactivates the promoter more weakly than Oct 2.1 and 2.3, in which the insert is absent (17) .
Although two different types of activation domain contain a high content of either acidic or proline residues, respectively, the region of Oct-2 between residues 161 and 186 does not form part of the N-terminal activation domain described in previous studies (21, 33) . Moreover, a high content of proline residues has also been shown to be characteristic of several inhibitory domains in different transcription factors such as the Drosophila homeodomain proteins even-skipped and paired (9) . It is therefore unlikely that this region normally functions as an activation domain and represses the IE promoter by a nonspecific squelching effect in which adaptor factors required for its activation are removed from the IE promoter (for a review, see reference 7) . In agreement with this observation, both in our previous experiments (17) and those described here, the inhibitory effect of Oct-2 was specific for the IE3 promoter and some others containing the octamer/TAATGA RAT motif and was not observed with the Rous sarcoma virus promoter (8) or with the HSV tk promoter in the vector pBL2 CAT (18) . Similarly, cotransfection of a plasmid expressing the isolated inhibitory domain relieved the inhibitory effect of Oct 2.5 on the IE3 promoter rather than enhancing it as would be expected if this region binds positively acting adaptor factors (Fig. 8) .
It is possible that the inhibitory effect is achieved by preventing the binding of other transactivating factors to their binding sites in the IE3 promoter adjacent to the octamer motif. This is unlikely, however, since the inhibitory effects of Oct 2.4 and 2.5 can also be observed in artificial promoters in which the TAATGARAT motif is located in a different context than in the IE promoter (17) . Moreover, in these promoters the activity in the presence of Oct 2.4 or 2.5 can be reduced below that observed with the same promoter in the absence of the octamer motif or with a mutant motif which cannot bind octamer-binding proteins (5).
The conclusion from these studies that Oct 2.4 and 2.5 can inhibit promoter activity by a mechanism which does not involve inhibiting the binding of other stimulatory factors is supported by the observation that the N-terminal inhibitory domain can inhibit a heterologous promoter when linked to the DNA-binding domain of GAL4. Hence, this domain can inhibit promoter activity via a different DNA-binding site in a different promoter when directed to this site via an appropriate DNA-binding domain, which suggests that the N-terminal region of Oct-2 contains an inhibitory domain capable of repressing IE promoter activity as seems to be the case for the Drosophila homeodomain proteins even-skipped and paired (9) . Interestingly, however, we observed that the inhibitory effect of Oct 2.5 on the IE3 promoter could be relieved by introducing the isolated inhibitory domain in trans in the absence of any DNA-binding domain. Hence, rather than having an inherently inhibitory effect, this domain may function by recruiting another inhibitory factor to the promoter, with this factor being titrated out by the isolated inhibitory domain, hence relieving this effect. Further studies will be required to define the precise mechanism by which this inhibitory region exerts its effect.
In conclusion, the data presented here indicate that the N-terminal region of Oct-2 is responsible for the inhibitory effects of specific Oct-2 isoforms on the IE3 promoter and is capable of achieving this effect when the stimulatory effect of the C-terminal region is abolished by mutation or deletion. The high levels observed in neuronal cells of forms such as Oct 2.4 and 2.5 (17) or the Oct-2c form (32) , which contain alterations or deletions inactivating the C-terminal region, indicate that these forms are likely to play a critical role in the inhibition of many octamer/TAATGARAT-containing promoters observed in neuronal cells, which in the case of the HSV IE promoters plays a critical role in producing latent rather than lytic infection following initial exposure to HSV (13, 15) .
